← brief for 2026-09-14 · Slowing decline

Effects of Renin-Angiotensin Inhibitors, Sodium-Glucose Cotransporter 2 Inhibitors, Mineralocorticoid Receptor Antagonists and Glucagon-Like Peptide 1 Receptor Agonists on Kidney Outcomes in Patients With Type 1 Diabetes: A Systematic Review and Meta-Analysis.

Article A Peer reviewed Meta-analysis or large trial

Key takeaways

A large review of many studies found SGLT-2 inhibitors, GLP-1 receptor agonists, and mineralocorticoid receptor antagonists all lower the risk of kidney failure in people with type 1 diabetes, just like they do for type 2. This gives doctors new options beyond older blood pressure pills.

Who did this work

Perry F · Leon SJ · Polecina K · Getachew R · Askin N · Ferguson T · Whitlock R · Zheng Z · Aldworth C · Katta A · Earl J · Beller Ferri M

Source

Article · PubMed, the drug frontier · 2026 Sep 13
https://pubmed.ncbi.nlm.nih.gov/42733137/